Alpha-1 Foundation: Travel Grants

The Alpha-1 Foundation offers Travel Grants to support attendance at scientific conferences and cross-training in Alpha-1 laboratories. Grants are typically awarded at $1,000, aimed at enhancing the understanding and research of Alpha-1 Antitrypsin Deficiency. The Foundation prioritizes funding requests that align with its mission to improve the lives of affected individuals and advance research in this field.

NOTE: The process of receiving requests for funding for Scientific Meeting Sponsorships or Travel Grants begins with announcements of the forthcoming opportunities. The document that is submitted by potential awardees is the LOI. This document is a brief summary of details associated with the meeting or the purpose of the travel.
Should the request for funding fall outside the grant review cycle, the Foundation will either provide a rapid review or a Grants Advisory Committee member will be appointed to review the request. A merit score and recommendation for funding will be provided to the Alpha-1 Foundation within two (2) months of the receipt of a request unless the request falls within the grant review cycle.
If the request falls within the grant review period, the Scientific Meeting ponsorship or Travel requests will be considered at the Foundation’s regular Grants Advisory Committee meeting, held in April
Grants Awards Program
The Grants Award Program is the Alpha-1 Foundation’s mechanism to fund a broad range of research that leads to improvements in the lives of people living with AAT Deficiency.
Travel Grants are generally funded at a level of $1,000.
Objective: Support travel to attend national and international scientific conferences or meetings to present AAT-related abstracts orObjective: Support cross-training at an established Alpha-1 laboratory by an established Alpha-1 investigator

Ineligibility

Please note that the Alpha-1 Foundation does not accept LOIs or grant applications from pharmaceutical companies, biotechs, or industry for its in-cycle grants programs. These entities may not be collaborators on any proposals.